MARATHON CAPITAL MANAGEMENT - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 203 filers reported holding PDL BIOPHARMA INC in Q2 2016. The put-call ratio across all filers is 2.73 and the average weighting 0.0%.

Quarter-by-quarter ownership
MARATHON CAPITAL MANAGEMENT ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q2 2016$79,000
-4.8%
25,0000.0%0.04%
-4.7%
Q1 2016$83,000
-5.7%
25,0000.0%0.04%
-8.5%
Q4 2015$88,000
-30.2%
25,0000.0%0.05%
-26.6%
Q3 2015$126,00025,0000.06%
Other shareholders
PDL BIOPHARMA INC shareholders Q2 2016
NameSharesValueWeighting ↓
KESTREL INVESTMENT MANAGEMENT CORP 1,465,000$3,853,0001.56%
SMH CAPITAL ADVISORS INC 93,708$246,0000.42%
West Family Investments, Inc. 627,800$1,651,0000.39%
KENNEDY CAPITAL MANAGEMENT LLC 7,082,858$18,628,0000.35%
ARMISTICE CAPITAL, LLC 1,800,000$4,734,0000.28%
BRANDES INVESTMENT PARTNERS, LP 3,936,719$10,354,0000.23%
ROCKY MOUNTAIN ADVISERS, LLC 14,300$38,0000.13%
Zebra Capital Management LLC 74,695$196,0000.09%
Connor, Clark & Lunn Investment Management Ltd. 5,968,105$15,696,0000.09%
CREDIT AGRICOLE S A 471,644$1,240,0000.06%
View complete list of PDL BIOPHARMA INC shareholders